Skip to search formSkip to main contentSkip to account menu

policosanol

Known as: policosanol [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Anticholesteremic AgentsFatty AlcoholsPlatelet Aggregation Inhibitors
POLICOSANOL CAP/TAB

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA).
Review
2016
Review
2016
The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.
Highly Cited
2016
Highly Cited
2016
A rheological and microstructural characterisation of bigels for cosmetic and pharmaceutical uses.
Highly Cited
2009
Highly Cited
2009
Regulation of HMGCoA Reductase Activity by Policosanol and Octacosadienol, a New Synthetic Analogue of Octacosanol
Octacosa-10,19-dien-1-ol is a newly synthesized long-chain alcohol, an unsaturated analogue of 1-octacosanol, the major component… 
Review
2005
Review
2005
Meta‐Analysis of Natural Therapies for Hyperlipidemia: Plant Sterols and Stanols versus Policosanol
Study Objective. To compare the efficacy and safety of plant sterols and stanols as well as policosanol in the treatment of… 
Highly Cited
2003
Highly Cited
2003
Effects of Policosanol and Lovastatin in Patients with Intermittent Claudication: A Double-Blind Comparative Pilot Study
Policosanol is a cholesterol-lowering drug with concomitant antiplatelet effects. The present study was undertaken to compare the… 
Highly Cited
2000
Highly Cited
2000
Effects of policosanol on postmenopausal women with type II hypercholesterolemia
This randomized, double-blind, placebo-controlled study was conducted to investigate the efficacy, safety and tolerability of… 
Highly Cited
1995
Highly Cited
1995
Treatment of Hypercholesterolemia in NIDDM With Policosanol
OBJECTIVE To determine whether elevated levels of cholesterol and low-density lipoprotein (LDL) cholesterol in non-insulin… 
Highly Cited
1994
Highly Cited
1994
Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
This randomized, double-blind, placebo-controlled study was conducted in 22 patients with type II primary hypercholesterolaemia… 
Highly Cited
1994
Highly Cited
1994
Carcinogenicity of policosanol in Sprague Dawley rats: a 24 month study.
The effects of policosanol (50-500 mg/kg) administered orally for 24 months to Sprague Dawley rats of both sexes were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)